Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Guyatt

Showing results (41-50 of 1,097) with videos related to

Pageof 110
Sort By:
Journal of Clinical Epidemiology|December 24, 2014
Copresentation of relative and absolute effects is essential to promote optimal interpretability of treatment effectsJason W Busse, Gordon H Guyatt
Annals of Internal Medicine|June 21, 2017
In severe aortic stenosis with intermediate surgical risk, TAVR was noninferior to SAVR for death or disabling strokeFrederick A Spencer, Gordon H Guyatt
Lancet (London, England)|September 21, 2002
How to spread informationJoel G Ray, Gordon H Guyatt
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 15, 1988
Guidelines for reading literature reviewsA D Oxman, G H Guyatt
Clinical Chemistry|February 17, 2019
Measurement of Treatment Effects Requires Instruments Responsive to Change Based on the Minimal Important DifferenceBradley C Johnston, Gordon H Guyatt
Chest|October 1, 1987
Rigorous evaluation. Greater need than everG H Guyatt, M T Newhouse
JAMA Internal Medicine|September 8, 2018
A Randomized Clinical Trial of n-of-1 Trials-Tribulations of a TrialReza D Mirza, Gordon H Guyatt
International Journal of Technology Assessment in Health Care|December 11, 1984
The ethics and feasibility of randomized trials of diagnostic technology: a replyG H Guyatt, M F Drummond
ACP Journal Club|February 7, 2002
Review: albumin administration is not associated with excess mortality in acutely ill patientsDeborah J Cook, Gordon H Guyatt
Pharmacoeconomics|November 3, 1997
Reassessing quality-of-life instruments in the evaluation of new drugsG H Guyatt, R J Jaeschke
Pageof 110

Showing results (41-50 of 1,097) with videos related to

Sort By:
Pageof 110
Journal of Clinical Epidemiology|December 24, 2014
Copresentation of relative and absolute effects is essential to promote optimal interpretability of treatment effectsJason W Busse, Gordon H Guyatt
Annals of Internal Medicine|June 21, 2017
In severe aortic stenosis with intermediate surgical risk, TAVR was noninferior to SAVR for death or disabling strokeFrederick A Spencer, Gordon H Guyatt
Lancet (London, England)|September 21, 2002
How to spread informationJoel G Ray, Gordon H Guyatt
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 15, 1988
Guidelines for reading literature reviewsA D Oxman, G H Guyatt
Clinical Chemistry|February 17, 2019
Measurement of Treatment Effects Requires Instruments Responsive to Change Based on the Minimal Important DifferenceBradley C Johnston, Gordon H Guyatt
Chest|October 1, 1987
Rigorous evaluation. Greater need than everG H Guyatt, M T Newhouse
JAMA Internal Medicine|September 8, 2018
A Randomized Clinical Trial of n-of-1 Trials-Tribulations of a TrialReza D Mirza, Gordon H Guyatt
International Journal of Technology Assessment in Health Care|December 11, 1984
The ethics and feasibility of randomized trials of diagnostic technology: a replyG H Guyatt, M F Drummond
ACP Journal Club|February 7, 2002
Review: albumin administration is not associated with excess mortality in acutely ill patientsDeborah J Cook, Gordon H Guyatt
Pharmacoeconomics|November 3, 1997
Reassessing quality-of-life instruments in the evaluation of new drugsG H Guyatt, R J Jaeschke
Pageof 110